Methylation at Global LINE-1 Repeats in Human Blood Are Affected by Gender but Not by Age or Natural Hormone Cycles by El-Maarri, Osman et al.
Methylation at Global LINE-1 Repeats in Human Blood
Are Affected by Gender but Not by Age or Natural
Hormone Cycles
Osman El-Maarri
1*, Maja Walier
2., Frank Behne
1., Jan van U ¨ u ¨m
1., Heike Singer
1, Amalia Diaz-Lacava
2,
Nicole Nu ¨sgen
1, Barbara Niemann
1, Matthias Watzka
1, Jochen Reinsberg
3, Hans van der Ven
3, Thomas
Wienker
2, Birgit Stoffel-Wagner
4, Rainer Schwaab
1, Johannes Oldenburg
1
1Institute of Experimental Hematology and Transfusion Medicine, University of Bonn, Bonn, Germany, 2Institute of Medical Biometry, Informatics and Epidemiology
(IMBIE), University of Bonn, Bonn, Germany, 3Department of Gynecological Endocrinology and Reproductive Medicine, University of Bonn, Bonn, Germany, 4Institute for
Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany
Abstract
Previously, we reported on inter-individual and gender specific variations of LINE-1 methylation in healthy individuals. In this
study, we investigated whether this variability could be influenced by age or sex hormones in humans. To this end, we
studied LINE-1 methylation in vivo in blood-derived DNA from individuals aged 18 to 64 years and from young healthy
females at various hormone levels during the menstrual cycle. Our results show that no significant association with age was
observed. However, the previously reported increase of LINE-1 methylation in males was reconfirmed. In females, although
no correlation between LINE-1 or Alu methylation and hormone levels was observed, a significant stable individual specific
level of methylation was noted. In vitro results largely confirmed these findings, as neither estrogen nor dihydrotestosterone
affected LINE-1 or Alu methylation in Hek293T, HUVEC, or MDA-kb2 cell lines. In contrast, a decrease in methylation was
observed in estrogen-treated T47-Kbluc cell lines strongly expressing estrogen receptor. The very low expression of
estrogen receptor in blood cells could explain the observed insensitivity of methylation at LINE-1 to natural hormonal
variations in females. In conclusion, neither natural cycle of hormones nor age has a detectable effect on the LINE-1
methylation in peripheral blood cells, while gender remains an important factor.
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Introduction
DNA methylation is an essential regulatory mechanism in gene
expression. In human adult somatic cells, it is present mainly at the
5
th carbon position of cytosines in a CpG context, while in iPS and
embryonic stem cells, it is present at non-CpG sites [1,2].
Moreover, two independent groups recently reported the presence
of 5-methylhydroxy cytosine in Purkinje neurons and granule cells
and in embryonic stem cells in mice [3,4]. CpG dinucleotides are
relatively depleted in the bulk of the genome, but are found in
clusters called CpG islands. When present at the promoter of a
gene, a highly methylated CpG island may significantly reduce the
expression of the downstream gene as is frequently observed in
promoter hypermethylation of tumor suppressor genes [5]. CpG
sites in repetitive elements, like LINEs and Alus that constitute
about 20% and 10% of the human genome, respectively [6,7,8],
are largely methylated in normal somatic tissue. This is believed to
suppress most of their transposition activity [9,10]. Since these
repeats make up about 30% of the human genome the degree of
methylation in these repeats will considerably reflect on the
average whole genome methylation. At the same time, it has to be
taken into account that not all L1 sequences in the genome are full
length thus it is to be expected that only a fraction of the Line-1
repeats contain a CpG promoter rich region.
Hence, methylation at LINE-1 repeats is gaining increasing
importance as a surrogate marker to distinguish normal from
pathological disease tissue. In most carcinogenic tissue hypo-
methylation of repetitive elements, and particularly LINE-1
elements, is often observed. This includes a wide range of tumors
[11], such as prostate adenocarcinomas [12], pancreatic endocrine
tumors [13], gastric cancer [14], epithelial ovarian cancer [15],
chronic myeloid leukemia [16], uterine cervix [17] and hepato-
cellular carcinomas [18]. Such LINE-1 hypomethylation was also
observed in estrogen-induced rat breast carcinogenesis [19], while
hypermethylation was observed during abnormal overgrowth of
human placenta, particularly in partial hydatidiform moles [20].
Additionally, LINE-1 methylation (increase as well as decrease)
was predicted to be an indicator for the influence of environmental
conditions and lifestyle habits on the genome. Exposure to
environmental pollutants like exhaust fumes (petrol) was observed
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more precisely showed that black carbon particles ((micro-
molar 2.5 mM) derived from traffic pollution induce hypomethyla-
tion of blood cells LINE-1 sequences. Pilsner et al [23] found a
decrease inLINE-1 methylation incordblood DNA to be associated
with maternal exposure to lead. Pavanello et al [24], on the other
hand, showed an increase of LINE-1 methylation in association with
higher exposure to polycyclic aromatic hydrocarbons (PAHs).
However, before LINE-1 methylation can be used as a marker
for pathological diseases or specific environmental exposure,
causes of ‘normal/healthy’ variations of LINE-1 in healthy
individuals should be thoroughly assessed. Gender, age and
hormone influence are some potential affecting factors. Previously,
we reported on inter-individual and gender specific variations at
LINE-1. Inter-individual variability showed a range of about 5–
25% differences, while the gender effect favored a higher
methylation in males [25].
In this study, we addressed the effect of age, the natural
hormonal variations in vivo during the menstrual cycle and in
vitro by treating different cell lines with estrogen, dihydrotestos-
terone and progesterone. Our results confirmed that age does not
significantly affect the global LINE-1 methylation which was also
showing significant inter-individual variation but considerable
stability during different days of the menstrual cycle over a period
of three to four months. Hormone treatment or natural variations
had no significant effect on LINE-1 methylation, neither on total
peripheral blood cells in women, or on HEK293, HUVEC or
MDA-Kb2, but only on T47-Kbluc, which strongly expresses the
estrogen receptor. Our results not only highlight the stability (i.e.
hormonal and age independence) of LINE-1 methylation in
peripheral total blood cells, but also the need to interpret male and
female methylation data separately.
Results
Age does not have a statistically significant effect on
methylation levels at LINE-1 but marginally at F8 locus in
females
The first hypothesis in this study was that age is affecting the
methylation levels in healthy male or female individuals. For this
purpose, we looked at the methylation levels of LINE-1, using a
degenerate amplification approach (that unspecifically amplifies
different genomic promoter LINE-1 loci; Supplementary Figure
S1-A), and at F8 specific locus in about 300 healthy individuals
ranging in age between 18-64 years. None of the studied loci
showed a correlation between the measured methylation levels and
age of the DNA sample. This was true for all samples collectively,
even when we divided the samples into five age groups: 18–20; 21–
30, 31–40, 41–50 and 51–64 (Table 1). However, a borderline
significance (p value of 0.067) was observed for all collective female
samples at F8 locus CpG-8. The same F8 locus did not show this
tendency at CpG-7, that is 19 bases upstream of CpG-8
(Supplementary Figure S1-C). The correlation with age in females
but not in males could be related to the phenomenon of the
skewed (and deterioration of) X-chromosome inactivation process
associated with aging [26,27] and its effect on the methylation at
the Xq28 where the F8 is located.
Gender-specific methylation levels at global LINE-1 and
F8 locus
Previously [25], we have shown that in 24-year old healthy
males and females, a significant association between LINE-1
methylation and gender exists: males were higher methylated. In
order to follow this male-female difference in different age groups
we analyzed the data generated in this study for a gender effect. A
0.94% higher methylation in males was observed for all combined
age groups (t-test p=0.014) (Table 1). When dividing all samples
into five different age groups (18–20, 21–30, 31–40, 41–50 and
51–64) males were higher methylated in all age groups, however,
significant difference was only observed in the age group of 51–64
(p value 0.029). The lack of significance in other groups could be
attributed to the relatively smaller sample size as compared to all
groups combined.
As control, we also investigated two X-linked specific CpG sites
in exon 14 of the F8 gene that we had reported earlier to show a
clear difference between males and females, with the latter being
less methylated [25]. In this F8 case, the lower methylation in
females could be explained by the general hypomethylation
observed at the inactive female X-chromosome and the hypo-
methylation in the body of unexpressed genes on the inactive X
[28,29]. Here again and also at the two studied CpG sites (in the
F8 locus), we could clearly see significant differences in all age
groups combined as well as in the individual age groups (apart
from a border line significance at CpG7 for age group 51–64
(p=0.053). (Table 1).
We observed a relative difference between male and female
methylation when comparing our previous study [25] with this one
(previous study=3.46%; this study=0.94%). This is due to the
fact that different bisulfite treatment protocols were used (agarose
bead method [30] vs. EpiTect bisulfite kit from Qiagen) and to
differences in annealing temperature influencing the average
methylation levels when using a degenerate primer amplification
approach (Supplementary Figure S2). In addition, the average age
in the first study was 24 years, while in this study we were
analyzing samples ranging in age between 18 and 64 years.
LINE-1 and Alu methylation is stable during different
stages of the menstrual cycle regardless of hormone
levels
The influence of estradiol, progesterone and testosterone levels
on the methylation levels at LINE-1 (SN-8 (CpG15) and SN-9
(Supplementary figure S1-A)) and Alu (SN-1 and SN-4 (Supple-
mentary figure S1-B)) in healthy females during different stages of
their menstrual cycle was tested using a mixed model. No
significant dependence of the methylation values on any one of the
three measured hormone levels was observed (p value 0.17-0.95)
(Table 2). As control, we tested the dependency of methylation at
CpGs within one studied locus (i.e.: LINE-1 SN-8 and SN-9; Alu
SN-1 and SN-4). Some dependency is expected as the two CpGs
which are amplified in one reaction and are close to each other,
tend to have correlated or dependent methylation levels [25].
Indeed, both CpGs within LINE-1 and within Alu show a
dependency on each other (within one locus) (p value for LINE-1
SN8 and SN9: 5E-04; p value for Alu SN1 and SN4: 1.25E-05).
However, no dependency between any one of the two CpGs in
LINE-1 and any one of the two CpGs in Alu was observed. This is
in contradiction to previously published data including our own
[25], possibly due to the relatively small number of independent
measurements of only 17 cases. In total, there were 165 samples
where LINE-1 and Alu methylation at 2 CpG sites at each locus
was measured. However, these were derived from only 17
independent individuals. Estradiol and progesterone are also
expected to show a correlation since during the menstruation
phase, both hormones are very low, while in the proliferative
phase as well as in the secretory phase, both have substantially
higher values. This dependency was observed as expected (p value
for estradiol and progesterone: 0.0032).
Parameters Affecting LINE-1 Methylation
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are stable over 3-4 months donation period
Next, we wanted to test the stability of the measured
methylation values over time within one woman and between
different women. For this purpose, we used an ANOVA variable
model approach. The variability parameter within one woman
was shown to be much lower (range between 0.61 and 4.01) than
between different women (range between 0.6 and 94.34) (Table 3).
Variability between women at LINE-1 was much more pro-
nounced than at Alu, with the latter being particularly stable at
Alu SN-4 (Table 3; Figure 1).
Hormone treatment of different cell lines
RT-PCRs and western blot of hormone recep-
tors. Qualitative RT-PCRs showed that estrogen receptor-1
is strongly expressed in T47D-Kbluc, moderately in Hek293T,
slightly in HUVEC and male and female peripheral blood cells.
Estrogen receptor 2 is moderately expressed in all cell lines,
relatively weaker expressed in male and even weaker in female
peripheral blood cells. Progesterone receptor is slightly expressed
in HUVEC, moderately in Hek293T and MDA-kb2 cells and
strongly in T47D-Kb2 cells but not detectable in peripheral
blood cells. Lastly, androgen receptor is strongly expressed in
Hek293T, MDA-kb2 and in T47D-Kbluc and slightly in male
and female peripheral blood cells (Figure 2). Western blots
against ER and AR largely confirmed the RT-PCR results and
showed that the ER protein (within the sensitivity of western
blot) is not detectable in peripheral blood cells but present in
T47D-Kb2 cell line (data not shown). The androgen receptor on
the other hand, was detected by western blot only in T47D-Kb2
and MDA-Kb2 cell lines, again confirming the RT-PCR results.
The primers used for the RT-PCRs are listed in Supplementary
Table S1.
Methylation levels at LINE-1 and Alu in T47D-KBluc are
affected by estradiol but not dihydrotestosterone. Sex
hormones could be a contributing factor to the gender
difference in methylation at least within repetitive elements. To
test this we treated HUVEC (primary endothelial cells) and
T47D-KBluc cell line with E2 (100 nM final concentration
corresponding to about 68-fold the upper normal physiological
levels of 400 pg/ml in healthy females) and HUVEC cells
and MDA-Kb2 with DHT (100 nM final concentration
corresponding to 36-fold the upper normal physiological levels
of 0.8 ng/ml in healthy females) for 48 hours. Next, we analyzed
methylation levels at Alu and LINE-1 repeats (with degenerate
primers). No difference was observed before and after treatment
or within controls for the DHT treatment. E2 treatment resulted
in a slight but significant drop in methylation in T47D-KBluc at
both LINE-1 CpGs and at Alu CpG1. A slight but statistically
significant drop in Alu methylation of CpG-1 in E2-treated
HUVEC was also observed (Figure 3).
Treatment of HEK293 cells with hormones over an
extended period of four weeks did not alter the DNA
methylation at LINE-1 elements. As we cannot specify the
time lapse required between hormone treatment and change
in DNA methylation levels or patterns we treated HEK293
cells with different hormones for an extended period of four
weeks. LINE-1 methylation was analyzed at one-week intervals.
No difference in level of methylation was observed (data not
shown).
Table 1. Methylation at Line-1 and F8 and its correlation with gender and age.
Region Male Female Gender Dif.
correlation with age
correlation
with age Ave. Dif. t-test (p)
Age Av. % SD n r p Av. % SD n r p
F8 CpG7 18–20 81.77 3.10 16 20.0857 0.7522 78.77 4.31 17 20.2774 0.2811 3.00 0.02919
21–30 82.57 3.59 73 0.1084 0.3609 78.79 3.55 76 0.0039 0.9733 3.77 0.00000
31–40 82.13 3.52 31 0.1491 0.4235 78.95 4.34 29 20.2488 0.185 3.18 0.00258
41–50 83.06 2.77 14 0.5015 0.0677 80.27 3.39 23 20.1289 0.5578 2.78 0.01400
51–64 81.24 3.06 19 20.0424 0.8631 78.95 2.55 10 20.0083 0.9819 2.29 0.05351
All 82.25 3.38 153 20.0444 0.5854 79.11 3.72 157 0.0649 0.4197 3.14 2.96E-14
CpG8 18–20 69.29 2.96 16 20.4584 0.0741 56.88 5.79 17 20.437 0.8679 12.41 1.17E-08
21–30 68.79 4.33 73 20.0194 0.8708 59.41 4.77 76 0.0464 0.6885 9.37 3.71E-25
31–40 69.40 6.46 31 20.1855 0.3177 57.96 5.82 29 0.0238 0.9008 11.44 1.00E-09
41–50 67.86 6.52 14 20.1351 0.6452 60.42 6.10 23 0.1324 0.5471 7.44 0.00126
51–64 68.01 5.24 19 20.1235 0.6144 61.41 5.43 10 0.0709 0.8456 6.60 0.00361
All 68.76 5.10 153 20.0845 0.2991 59.18 5.49 157 0.1462 0.0677 9.58 1.87E-43
L1 CpG15 18–20 40.68 4.57 15 20.3883 0.1526 39.24 3.16 15 20.1189 0.6729 1.45 0.32157
21–30 39.60 2.85 67 20.1117 0.3679 38.61 4.09 78 0.1091 0.3384 0.99 0.09856
31–40 38.80 2.85 30 20.0118 0.9506 38.64 3.28 33 20.0322 0.8588 0.16 0.83534
41–50 39.03 3.55 17 20.3871 0.1247 38.23 3.48 21 20.489 0.0245 0.79 0.49372
51–64 39.89 2.43 20 0.3407 0.1415 37.89 2.16 11 20.2965 0.3758 2.01 0.02975
All 39.49 3.08 149 20.0531 0.5205 38.54 3.55 159 20.0764 0.3383 0.94 0.01493
The samples were analyzed in 5 groups of 10 years intervals except for the first group and collectively in all samples.
SD: standard deviation; n: number of individuals; r: Pearson correlation coefficient.
doi:10.1371/journal.pone.0016252.t001
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In this study, we addressed parameters that could possibly
contribute to the variability of methylation, mainly at LINE-1
repetitive regions. The stability over a 3–4 months period, the inter-
individual variations, and the effects of age, gender, and sex
hormones were thoroughly investigated. All of these parameters,
with the exception of gender, were seen to not affect levels of DNA
methylation in peripheral blood cells as inferred from methylation of
repetitive DNA. However, estrogen was an exception as it induced
hypomethylation of LINE-1 in an in-vitro system in T47-Kb2
carcinogenic cell line that strongly expresses the ER-alpha as
detectable by RT-PCR.
Our data show that some degree of variability exists at F8 single
loci and at LINE-1 and Alu repeats. The two CpG sites in the F8
locus were the most variable (SD ranging between 3.38 and 5.49).
This is consistent with our previous study [25] and confirms earlier
reports that used similar sensitive quantitative methods to investigate
the variability of methylation at several single loci [31,32]. Our data
also confirm the lack of significant correlation between LINE-1
methylation and age and the stability over time (3–4 months period)
that has been reported by others [11,33,34,35,36]. Several studies
have investigated the effect of age on LINE-1 methylation. However,
none found a statistically significant effect. Nevertheless, Bollati et al
and Iacopetta et al,described a decrease tendency associated with age
(summarized in Supplementary Table S2) [11,33,34,35,37,38].
Others and we previously reported gender difference at LINE-1,
which was also confirmed in this study [25,37]. On the other hand,
several other studies [11,34,35,38] that investigated methylation at
global LINE-1 failed to detect such global differences in
methylation between males and females (these studies are
summarized in Supplementary Table S2). This could be due to
several factors: 1) different detection methods, sensitivity of the
method, different tissues studied and size and age of the studied
samples; 2) specificity of the primers and whether they selectively
amplify the equally methylated regions in both genders or target
differentially methylated X-Linked regions; 3) annealing temper-
ature used to amplify the genome-wide dispersed LINE-1
elements. Indeed, we found a clear correlation between annealing
temperature and differences in methylation between males and
females with more pronounced differences observed at higher
temperatures (Supplementary Figure S4). This is probably due to
the specificity of amplification of more gender-specific LINE-1
differentially methylated regions at higher temperatures.
However, what are these gender-specific differentially methyl-
ated regions and where are they located in the genome? The main
source we could think of is the X-chromosome inactivation that is
characterized by a hypomethylated inactive X-chromosome. This
has been confirmed for single copy genes on the inactive X [29–
30] but the methylation status of specific LINE-1 sequences has
not been directly studied to date. However, from the data
presented in this study we cannot inferred if this observed female
Line-1 hypomethylation could be originated solely from the
inactivated X or whether autosomal regions would also contribute
to this phenomenon. Detailed future study of methylation of
autosomal and X-linked specific Line-1 regions are necessary to
further clarify this phenomenon (this is currently being addressed
by our group).
Once we had reconfirmed, using a large sample cohort, that
gender is an important factor to predict LINE-1 methylation, we
investigated whether sex hormones also contribute to this effect in
addition to the process of X-chromosome inactivation, i.e.
estrogen could be responsible for the decrease in methylation
females or testosterone could increase the methylation in males.
Although several studies addressed the effect of 17 b-estradiol,
none could establish a universal link between estrogen and
methylation levels. Aniagu et al found a hypomethylation effect of
E2 in HepG2 cell lines but not in primary human hepatocytes
[39]. Kovalchuck et al detected a loss of global methylation and
LINE-1 hypomethylation in induced mammary carcinomas in
estrogen treated female August Copenhagen Irish rats [19]. Feng
et al, [40] on the other hand, found a strong association between
the promoter methylation status of several genes and the
expression patterns of estrogen and progesterone receptor genes.
Hence, the effect of estrogen on methylation most likely depends
on cell type, tissue and DNA sequence.
Hereon we addressed the specific question of whether hormones
affect methylation of LINE-1 and Alu repeats. We investigated this
using two sets of samples. First, an in vitro cell culture system using
human cell lines (HEK293, HUVEC, T47D-KBluc, MDA-kb2)
that have defined but different expression patterns of androgen,
progesterone and estrogen receptors. These cell lines were treated
with estrogen, progesterone or DHT. The second set is from 17
healthy female blood donors where three blood samples were
withdrawn during each menstrual cycle (for 3–4 consecutive
months) during the menstruation phase, at the end of the
proliferative phase and at the middle of the secretory phase. The
peripheral blood cells from which DNA is extracted are
collectively called leukocytes. These include different subgroups
that differ in lifespan and percentages among total leukocytes.
Table 2. The influence of different hormone levels as fixed
and women and month of cycle as random effects on
different methylation measurements calculated by a mixed
linear model is shown in this table.
Effect dependent DenDF FValue ProbF
Estradiol L1_SN9 103 1.17 0.2820
Estradiol L1_SN8 103 0.01 0.9086
Estradiol ALU_SN4 95 0.82 0.3669
Estradiol ALU_SN1 105 1.00 0.3208
Estradiol Progesterone 94 9.14 0.0032
Estradiol Testosterone 83 0.66 0.4194
Progesterone L1_SN9 92 1.92 0.1697
Progesterone L1_SN8 92 0.01 0.9149
Progesterone ALU_SN4 84 0.52 0.4732
Progesterone ALU_SN1 94 0.02 0.8861
Progesterone Testosterone 76 1.46 0.2308
Testosterone L1_SN9 81 0.00 0.9500
Testosterone L1_SN8 81 0.53 0.4679
Testosterone ALU_SN4 77 0.87 0.3546
Testosterone ALU_SN1 82 0.81 0.3721
L1_SN8 L1_SN9 112 13.03 0.0005
L1_SN8 ALU_SN4 102 0.58 0.4480
L1_SN8 ALU_SN1 112 0.81 0.3705
L1_SN9 ALU_SN4 102 0.38 0.5401
L1_SN9 ALU_SN1 112 0.05 0.8293
Alu_SN1 ALU_SN4 104 21.06 1.25E-05
The dependence of hormone level on each other’s and the dependence of
methylation at each locus on other loci are also shown. The probability of ,0.05
is considered as significant. (DenDF: Denominator degrees of freedom; FValue:
Quantile of the F distribution; ProbF: P value of the F distribution).
doi:10.1371/journal.pone.0016252.t002
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ophils and basophiles that make up (on average) 55.5%, 35%,
8.6%, 3.5% and 0.75%, respectively. For most of them, lifespan in
the blood stream is still not very well defined although the
literature suggests a lifespan of 25 hours to 5.4 days for
neutrophils, several weeks to years for lymphocytes, 1–3 days for
monocytes, 26 hours for eosinophils, and 1–3 days for basophiles
[41,42,43,44,45]. Therefore, about 65% of the nucleated periph-
eral blood cells are relatively short lived and would be subject to
monthly hormonal fluctuations during the female menstrual cycle.
In both samples sets, no link could be established between either
of the hormones and methylation levels at different repeat regions
(Alu and LINE-1) with the exception of a slight but significant
hypomethylation effect of estrogen on the T47D-Kbluc cells. The
sensitivity of the latter cell line to estrogen could be explained by
the higher expression of estrogen receptors (Figure 2) and the
presence of ER-alpha in this cell line, but not in the other cell lines
or the peripheral blood-derived cells as seen by western blot (data
not shown). Therefore, the estrogen receptor may mediate the
hypomethylation effect by either lowering the expression of a
Figure 1. Average methylation levels at LINE-1 (SN9 and SN8) and Alus (SN1 and SN4) A) on three dates during the menstrual cycle
(Date 1: during the menstruation phase, 55 samples; Date 2: near the ovulation phase, 56 samples; Date 3: during middle of
secretory phase, 53 samples). The data are the averages of all participating women and all measurements. B) of all blood samples taken from a
given female donor. The graph shows the inter-individual variability between donors that is persistent over 3–4 months period. The donor number is
given on the horizontal axis.
doi:10.1371/journal.pone.0016252.g001
Table 3. The stability of the methylation measurement at Line-1 and Alu both within (estimated by mean square of the residuals:
Var_Error) and between women (estimated by mean square of the model: Var_Model) was calculated using the ANOVA approach.
Model (Variability between women) Error (Variability within women)
Dependent DF Var Cl_1 STD Cl_2 DF Var Cl_1 STD Cl_2
L1_SN9 16 94.34 7.23 9.71 14.78 147 4.02 1.80 2.00 2.26
L1_SN8 16 52.83 5.41 7.27 11.06 147 2.13 1.31 1.46 1.65
Alu_SN4 14 0.65 0.59 0.81 1.27 135 0.61 0.70 0.78 0.89
Alu_SN1 16 12.09 2.59 3.48 5.29 149 1.29 1.02 1.14 1.28
Upper and lower confidence limits are also shown. (DF: degree of freedom, Var: calculated variability parameter, Cl_1 and 2: Confidence limits of the standard deviation,
STD: standard deviation).
doi:10.1371/journal.pone.0016252.t003
Parameters Affecting LINE-1 Methylation
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methylating factor. We also cannot exclude that this specific cell
line is particularly more prone to such an estrogen effect due to the
fact that it is a mammary carcinoma cell line that could have
multiple cellular transformations making it vulnerable to an
estrogen effect. This is in agreement with the fact that sex
hormones have different epigenetic effects on male and female
brain development, which could be induced by differences in
promoter methylation and expression of estrogen and progester-
one receptor [46]. On the other hand the absence of an effect of
natural hormone variations during the natural menstrual cycle on
the LINE-1 and Alu methylation levels in blood cells could be due
to the relatively small samples size that was available for this study.
Hereon, we could not exclude whether other non-studied repeats
or single loci could be even more affected by other hormones (not
only estrogen) in the cell lines studied or in blood cells. Future
detailed genome wide studies are needed to explore this possibility.
In this study, we show that methylation at LINE-1 elements is
independent of several factors. Indeed, we found that neither age
nor natural hormone levels are modulating the methylation levels.
However, gender remains an influential factor. These results
highlight that variability of methylation at LINE-1 within one
gender is stemming from three sources. First: experimental
conditions related to the quantitative methods used. Second:
environmental factors including diet, life styles and pollution.
Third: genetic factors. How much the last two potential sources
contribute to the variability of methylation at LINE-1 remains
unknown. Our study eliminated potential factors that could affect
the variability of LINE-1 methylation and it will pave the way for
larger studies to examine, in more detail, the genetic and
environmental effect on the levels of methylation of LINE-1
genome wide.
Materials and Methods
Ethics statement
All samples from all subjects were obtained upon written
informed consent. The local Ethics Committee of the University
Clinics of Bonn approved the study (approval numbers: 106/05
and 240/07).
DNA samples
DNA from 500 healthy individuals distributed overall age groups
(18–64 years old) was available for this study from blood donors
attending the blood donation unit at the Institute of Experimental
Hematology and Transfusion Medicine, University of Bonn.
Additional samples from healthy female subjects were collected
from young healthy volunteers (20–35 years old). Every female
donor was asked to give blood three times per month for a duration
of three to four months. The first blood sample was taken duringthe
menstruation phase, the second near the end of the proliferative
phase at theovulation time (estimatedfrom thecycle length) and the
third at the middle of the secretory phase. Eleven, four and two
women were able to give samples over four, three and two months,
respectively.Onlyone womanwithdrewfrom the study.Fromevery
blood donation, levels of estradiol, progesterone and testosterone
were measured according to standard protocols.
Methylation analysis
Bisulfite treatment was done using the EpiTect kit from Qiagen
(Hilden, Germany) according to the manufacturer’s procedure.
PCRs were performed using previously published primers [25]
and a hot-start Taq polymerase (HOT FIREPol from Solis
BioDyne, Tartu, Estonia). Detailed information about the position
of the primers used for the amplification of degenerate LINE-1
and Alu sequences can be found in Supplementary Figure S1. For
accurate quantitative methylation analysis we used one of two
assays, either a pyrosequencing based assay or the SIRPH protocol
[47,48,49]. Quantitative methylation at one specific CpG site
(CpG15 Supplementary Figure S1-A) at LINE-1 promoter was
measured using the pyrosequencing technique (for age samples).
This assay was chosen as it has a higher throughput and is easier to
use for large number of samples.
Using the pyrosequencing assay we analyzed only one CpG site
flanking the pyrosequencing primer. The reason for this is based
on the fact that a pyrosequencing assay requires input of a DNA
sequence to read the methylation levels while synthesizing the
DNA strand according to the user-entered sequence. Since LINE-
1 sequences are highly variable, we found that the longer the
distance to the sequence start the greater the deviation from the
consensus sequence and the less accurate the reflection on the
Figure 2. RT-PCR of the receptors in MDA-Kb2, T47-Kbluc, HEK293T, HUVEC cells and male and female peripheral blood derived
cells. Estrogen Receptor 1 (ER-1 (alpha)), Estrogen Receptor 2 (ER-2 (beta)), Progesteron Receptor (PR), and Androgen receptor (AR).
doi:10.1371/journal.pone.0016252.g002
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includes the sequencing of 50 clones illustrates this phenomenon.
For only 50 sequenced clones, corresponding to different LINE-1
loci dispersed all over the genome, it would be possible to read the
methylation of about 82%, 76%, 36% and 16% at CpGs 1, 2, 3
and 4, respectively. Already at CpG number 7 no clones could be
read. Therefore and because of this bias, we studied only one CpG
site directly flanking the pyrosequencing primer.
On the other hand, the SIRPH method was used for measuring
methylation at two promoter specific LINE-1 CpG sites (SN-8
(CpG15) and SN-9; Supplementary Figure S1-A) and two Alu
specific CpG sites (SN-1 and SN-4; Supplementary Figure S1-B) in
the control samples of the menstrual cycle and the hormone-
treated cell line [47,48]. This assay was used for these samples
because it is highly quantitative and very sensitive and can
therefore detect very small variations of less than 1%. However,
the throughput is less than with the pyrosequencing assay which
makes SIRPH suitable for a relatively small number of samples.
Cell culture and hormone treatment
Cell lines used in this study. Four different cell lines were
used in this study: Hek293T (female), HUVEC (mixture of male
and female), T47-Kbluc (female breast cancer cell line) [50] and
MDA-kb2 (female breast cancer cell line) [51].
Figure 3. Effect of Hormone treatment on DNA methylation levels at A) LINE-1 and B) Alu. The 48 hours hormone response in HUVEC,
T47D-KBluc and MDA cells. T and E stands for dihydrotestosterone and estradiol respectively. Each value corresponds to three different cell culture
treatments, each measured thrice for methylation (making a total of 9 measurements).
doi:10.1371/journal.pone.0016252.g003
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medium as follows: Hek293T were cultivated in DMEM Glc 1 g/l
with L-Gln, T47D-KBluc were cultivated in RPMI 1640 with L-
Glutamine, MDA-Kb2 cells were cultivated in Leibovitz L15,
while HUVEC cells were cultivated in endothelial cell basal
medium. All mediums were without phenol red and supplemented
with 10% charcoal-treated FBS, penicillin 200 U/ml,
streptomycin 0.5 mg/ml and amphotericin 25 mg/ml. The cells
were treated with 4,5 alpha-Dihydrotestosterone (DHT; Sigma-
Aldrich, ordering number: 10300) or with 17 beta-estradiol (E2;
Sigma-Aldrich, ordering number: E2758) or with progesterone (4-
Pregnenr-2,20-dione; Sigma-Aldrich, ordering number: P8783).
While testosterone itself is a potent androgenic hormone, it
nevertheless represents a prohormone that can be converted
enzymatically into a threefold more potent androgen 5 alpha-
DHT (5-alpha-reductase pathway) or even into estradiol (E2;
aromatase or CYP19A1 pathway) [52]. Therefore, we used
dihydrotestosterone instead of testosterone as an androgen due
to its inability to enter the estrogen pathway of hormonal
regulation. The different hormones were dissolved either in
ethanol or in DMSO or in cyclodextrine ((2-Hydroxypropyl)- b-
cyclodextrine; Sigma; product number C0926). A 30 mM working
solution of each hormone was used to prepare a 1:300 dilution in
the culture medium for every specific cell line. This is
corresponding to 0.1 nmole/ml of medium or to 27 ng/ml,
29 ng/ml and 31 ng/ml for estrogen, dihydrotestosterone and
progesterone, respectively. In other words, this corresponds to
about 68-fold, 36-fold and 1.8-fold the upper physiological
concentration (in females) for estrogen, dihydrotestosterone and
progesterone, respectively. For every assay, the cells were
incubated in the respective hormones for 48 hours. A 48 hour
treatment was chosen based on a previous report of a detectable
effect of estrogen on chromatin modifications during this
treatment time [53].
Luciferase assays. The responsiveness of the cell lines
MDA-kb2 (responsive for testosterone) and T47D-KBluc
(responsive for estradiol) for hormone treatment was measured
by a luciferase assay as both cell lines contain a hormone
responsive element upstream of luciferase reporter gene [50,51].
The ‘Luciferase Reporter Gene Assay, high sensitivity’ from
Roche was used (ordering number: 11 669 893 001). We treated
the MDA-kb2 cells with either 100 nM DHT or with 100 nM E2
(only ethanol was used as negative control) and performed the
luciferase assay. The response to DHT was about 14-fold higher
than the ethanol blank, while the response to estrogen was about
4-fold higher than the blank. Induction of T47D-KBluc cells with
E2 and DHT gave 7-fold and 2-fold higher response, respectively,
than the ethanol blank control. We then tested different solvent
mediums, namely ethanol, DMSO and cyclodextrine for the
hormone preparation and found little differences between the
three mediums (data not shown). Therefore, and for simplicity of
preparation, we continued to use ethanol in preparation of the
hormone working solutions.
RT-PCRs and western blots. RT-PCR and western blots
where done according to standard procedures. Briefly, blood
cells, HEK293, T47D, MDA and HUVEC cells were lysed in
RIPA buffer (Sigma, Product No. R 0278) and the protein
concentration was measured by Lowry assay. Equal amounts of
each protein sample (30 ı `g) were separated by electrophoresis
on SDS-PAGE (BIORAD, Cat. No. 161-1101)) and blotted
onto nitrocellulose membrane (GE Healthcare, Pack. No.
RPN303F). Blots were incubated as indicated with primary
antibodies raised against AR (Sigma, Product-No. A9853), and
ER (recognizing both ERa and ERa ˆ: Sigma, Product-No.
E0521). The blots were developed with the chemiluminescent
substrate solution CDP-Star
TM (Sigma, product No. C0712)
using specific alkaline phosphatase-conjugated anti-IgG specific
antibodies. Primers used fort h eR T - P C R sa r el i s t e di n
Supplementary Table S1.
Statistical analysis
Correction of variation between different plates and
trend line within a given plate. Since the number of
samples used to study the effect of age was too large for
analysis in one 96-well plate, the samples had to be analyzed
over several plates. This resulted in differences in the general
average between plates, which had to be corrected before all
samples were pooled together for further statistical evaluations.
The two observed deviations were a trend line of decrease or
increase over a plate (due to processing time) and different
average values between plates. These observed experimental
issues were corrected as follows: A linear regression for the trend
line within each plate was calculated and the measured
methylation values were corrected accordingly, so that after
correction the linear regression of a given plate was parallel to
the X-axis. In a final step, the individual plates were normalized
according to the global average. This correction of
experimentally introduced biases did not change the expected
results of the controls in the factor VIII region. Therefore, we
expect that this correction will have a minor effect (if any) on
other tested regions. The data before and after correction are
represented by box plots in Supplementary Figure S6-A, the age
distribution in every experimental group is shown in Supple-
mentary Figure S6-B.
Correlation with age and gender. Pearson correlation was
applied to test the correlation between age and methylation, while
the gender effect was tested by t-test.
Effect of methylation and hormones on each other and
during different stages of the menstrual cycle. In this study,
we repeatedly (over a 3-4 months period) measured hormone and
methylation levels at selected CpG sites in different female donors
at three different time points during the menstrual cycle. The
dependence of repeated measurements in each particular female
blood donor violates a basic assumption in the linear regression
model, which ignores dependent observations on the same subject.
On the other hand, by using an ANOVA for repeated
measurements or a linear regression model, an estimation of the
variability for all samples could be given. However, a measure of
between-subject variability is not integrated. Since measurements
in one woman are expected to be much more similar than
measurements in different women, regression and ANOVA
require an extension that incorporates the within-subject
dependence. Therefore, a mixed linear model seemed to be the
most appropriate due to the structure of the data. The co-variance
structure is specified by standard variance components. In this
model, the women and their sampling dates (during the month)
represent the additional random effects and the fixed effect is
either the methylation or the hormone level.
Variability of the methylation between different female
donors. To examine differences (if any) in methylation at L1 (at
two CpG sites) and Alu (at two CpG sites) between different
women we used the ANOVA model. For this calculation, we
considered the methylation value as dependent variable and the
women as effect.
If inter-individual differences between different women exist the
variability of methylation between women should be higher than
the variability of different measurements in one woman.
Therefore, by calculating the variability between different women
Parameters Affecting LINE-1 Methylation
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individual methylation differences.
Supporting Information
Figure S1 Bisulfite converted and normal sequence of studied
Line-1 (A), Alu (B) repeats and F8 (C), the used PCR, SIRPH or
pyrosequencing primers sequences are labeled.
(PDF)
Figure S2 In this diagram, the effect of annealing temperature
on average methylation as measured by SIRPH reaction is shown.
The higher the annealing temperature used the bigger is the
difference between males and females for this CpG site in LINE-1
sequence. Four males and four females aged 21 years were used for
this experiment.
(PDF)
Figure S3 50 sequenced clone of LINE-1 derived from male
peripheral blood derived PCR products (Line-1 degenerate
primers). The consensus sequence is shown in bold below the
sequences. This figure shows the polymorphisms at CpG sites, the
non CpG/TpG dinucleotide at the CpGs number 15, 16, 17, 18,
19, 20, 21 and 22 are highlighted in the red boxes. The oval boxes
correspond to deviations from the consensus sequence at non CpG
sites. Deviations from the consensus sequence that is used by the
pyrosequencer to read the methylation averages causes the
synthesis of the DNA strands to hold or to incorporate the wrong
nucleotide in the wrong timing thus affecting the quantitative
reading of the methylation values. This is particularly illustrated by
the percentage of readable CpGs at every site which start with
82% at position 1 (CpG15) and end with 0% at position 7
(CpG21).
(PDF)
Figure S4 A) Methylation value distribution in the six
experimental groups before and after correction. In every group,
the number of males and females is also shown. B) Age distribution
in the six experimental groups. In every group the number of
males and females is also shown.
(PDF)
Table S1 Primer sequences used in this study.
(PDF)
Table S2 Summary findings of several studies that analyzed
LINE-1 global methylation in healthy human individuals.
(PDF)
Acknowledgments
We would like to thank the blood donors for participating in this study and
Gisela Gerlings and Sabine Dentler for English editing of the manuscript.
The authors declare no competing interest.
Author Contributions
Conceived and designed the experiments: OEM. Performed the experi-
ments: FB JvU ¨ HS NN. Analyzed the data: OEM MW ADL TW.
Contributed reagents/materials/analysis tools: BN MW JR HvdV BSW
RS JO. Wrote the paper: OEM.
References
1. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, et al. (2009) Human
DNA methylomes at base resolution show widespread epigenomic differences.
Nature 462: 315–322.
2. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, et al. (2010) Dynamic changes
in the human methylome during differentiation. Genome Res 20: 320–331.
3. Kriaucionis S, Heintz N (2009) The nuclear DNA base 5-hydroxymethylcytosine
is present in Purkinje neurons and the brain. Science 324: 929–930.
4. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al. (2009)
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian
DNA by MLL partner TET1. Science 324: 930–935.
5. Tellez CS, Shen L, Estecio MR, Jelinek J, Gershenwald JE, et al. (2009) CpG
island methylation profiling in human melanoma cell lines. Melanoma Res 19:
146–155.
6. Weiner AM (2002) SINEs and LINEs: the art of biting the hand that feeds you.
Curr Opin Cell Biol 14: 343–350.
7. Deininger PL, Moran JV, Batzer MA, Kazazian HH, Jr. (2003) Mobile elements
and mammalian genome evolution. Curr Opin Genet Dev 13: 651–658.
8. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial
sequencing and analysis of the human genome. Nature 409: 860–921.
9. Thayer RE, Singer MF, Fanning TG (1993) Undermethylation of specific LINE-
1 sequences in human cells producing a LINE-1-encoded protein. Gene 133:
273–277.
10. Hata K, Sakaki Y (1997) Identification of critical CpG sites for repression of L1
transcription by DNA methylation. Gene 189: 227–234.
11. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N,
Tangkijvanich P, et al. (2004) Distinctive pattern of LINE-1 methylation level
in normal tissues and the association with carcinogenesis. Oncogene 23:
8841–8846.
12. Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC, et al. (2007) Hypermethylation
of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate
adenocarcinoma and their relationship to clinicopathological features. J Pathol
211: 269–277.
13. Choi IS, Estecio MR, Nagano Y, Kim do H, White JA, et al. (2007)
Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine
tumors (pancreatic endocrine tumors and carcinoid tumors). Mod Pathol 20:
802–810.
14. Kaneda A, Tsukamoto T, takamura-Enya T, Watanabe N, Kaminishi M, et al.
(2004) Frequent hypomethylation in multiple promoter CpG islands is associated
with global hypomethylation, but not with frequent promoter hypermethylation.
Cancer Sci 95: 58–64.
15. Pattamadilok J, Huapai N, Rattanatanyong P, Vasurattana A, Triratanachat S,
et al. (2008) LINE-1 hypomethylation level as a potential prognostic factor for
epithelial ovarian cancer. Int J Gynecol Cancer 18: 711–717.
16. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, et al.
(2008) Repetitive DNA hypomethylation in the advanced phase of chronic
myeloid leukemia. Leuk Res 32: 487–490.
17. Shuangshoti S, Hourpai N, Pumsuk U, Mutirangura A (2007) Line-1
hypomethylation in multistage carcinogenesis of the uterine cervix. Asian
Pac J Cancer Prev 8: 307–309.
18. Takai D, Yagi Y, Habib N, Sugimura T, Ushijima T (2000) Hypomethylation of
LINE1 retrotransposon in human hepatocellular carcinomas, but not in
surrounding liver cirrhosis. Jpn J Clin Oncol 30: 306–309.
19. Kovalchuk O, Tryndyak VP, Montgomery B, Boyko A, Kutanzi K, et al. (2007)
Estrogen-induced rat breast carcinogenesis is characterized by alterations in
DNA methylation, histone modifications and aberrant microRNA expression.
Cell Cycle 6: 2010–2018.
20. Perrin D, Ballestar E, Fraga MF, Frappart L, Esteller M, et al. (2007) Specific
hypermethylation of LINE-1 elements during abnormal overgrowth and
differentiation of human placenta. Oncogene 26: 2518–2524.
21. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, et al. (2007) Changes in
DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res
67: 876–880.
22. Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, et al. (2009)
Rapid DNA methylation changes after exposure to traffic particles. Am J Respir
Crit Care Med 179: 572–578.
23. Pilsner JR, Hu H, Ettinger A, Sanchez BN, Wright RO, et al. (2009) Influence of
prenatal lead exposure on genomic methylation of cord blood DNA. Environ
Health Perspect 117: 1466–1471.
2 4 . P a v a n e l l oS ,B o l l a t iV ,P e s a t o r iA C ,K a p k aL ,B o l o g n e s iC ,e ta l .( 2 0 0 9 )
Global and gene-specific promoter methylation changes are related to
anti-B[a]PDE-DNA adduct levels and influence micronuclei levels in
polycyclic aromatic hydrocarbon-exposed individuals. Int J Cancer 125: 1692–
1697.
25. El-Maarri O, Becker T, Junen J, Manzoor SS, Diaz-Lacava A, et al. (2007)
Gender specific differences in levels of DNA methylation at selected loci from
human total blood: a tendency toward higher methylation levels in males. Hum
Genet 122: 505–514.
26. Knudsen GP, Pedersen J, Klingenberg O, Lygren I, Orstavik KH (2007)
Increased skewing of X chromosome inactivation with age in both blood and
buccal cells. Cytogenet Genome Res 116: 24–28.
Parameters Affecting LINE-1 Methylation
PLoS ONE | www.plosone.org 9 January 2011 | Volume 6 | Issue 1 | e1625227. Busque L, Paquette Y, Provost S, Roy DC, Levine RL, et al. (2009) Skewing of
X-inactivation ratios in blood cells of aging women is confirmed by independent
methodologies. Blood 113: 3472–3474.
28. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, et al. (2005)
Chromosome-wide and promoter-specific analyses identify sites of differential
DNA methylation in normal and transformed human cells. Nat Genet 37:
853–862.
29. Hellman A, Chess A (2007) Gene body-specific methylation on the active X
chromosome. Science 315: 1141–1143.
30. Hajkova P, el-Maarri O, Engemann S, Oswald J, Olek A, et al. (2002) DNA-
methylation analysis by the bisulfite-assisted genomic sequencing method.
Methods Mol Biol 200: 143–154.
31. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, et al. (2009) DNA
methylation differences after exposure to prenatal famine are common and
timing- and sex-specific. Hum Mol Genet 18: 4046–4053.
32. Schneider E, Pliushch G, El Hajj N, Galetzka D, Puhl A, et al. (2010) Spatial,
temporal and interindividual epigenetic variation of functionally important DNA
methylation patterns. Nucleic Acids Res 38: 3880–3890.
33. Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, et al. (2009) Decline in
genomic DNA methylation through aging in a cohort of elderly subjects. Mech
Ageing Dev 130: 234–239.
34. Iacopetta B, Grieu F, Phillips M, Ruszkiewicz A, Moore J, et al. (2007)
Methylation levels of LINE-1 repeats and CpG island loci are inversely related in
normal colonic mucosa. Cancer Sci 98: 1454–1460.
35. Jintaridth P, Mutirangura A (2010) Distinctive patterns of age-dependent
hypomethylation in interspersed repetitive sequences. Physiol Genomics.
36. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, et al. (2008)
Intra-individual change over time in DNA methylation with familial clustering.
JAMA 299: 2877–2883.
37. Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, et al. (2010) Implications
of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 16:
1682–1689.
38. Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, et al. (2009) Global
DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics
and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 18:
1041–1049.
39. Aniagu SO, Williams TD, Chipman JK (2009) Changes in gene expression and
assessment of DNA methylation in primary human hepatocytes and HepG2 cells
exposed to the environmental contaminants-Hexabromocyclododecane and 17-
beta oestradiol. Toxicology 256: 143–151.
40. Feng W, Shen L, Wen S, Rosen DG, Jelinek J, et al. (2007) Correlation between
CpG methylation profiles and hormone receptor status in breast cancers. Breast
Cancer Res 9: R57.
41. Tough DF, Sprent J (1995) Lifespan of lymphocytes. Immunol Res 14: 1–12.
42. Whitelaw DM (1966) The intravascular lifespan of monocytes. Blood 28:
455–464.
43. Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, et al. (2010) In vivo
labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 116:
625–627.
44. Steinbach KH, Schick P, Trepel F, Raffler H, Dohrmann J, et al. (1979)
Estimation of kinetic parameters of neutrophilic, eosinophilic, and basophilic
granulocytes in human blood. Blut 39: 27–38.
45. Asquith B, Borghans JA, Ganusov VV, Macallan DC (2009) Lymphocyte
kinetics in health and disease. Trends Immunol 30: 182–189.
46. McCarthy MM, Auger AP, Bale TL, De Vries GJ, Dunn GA, et al. (2009) The
epigenetics of sex differences in the brain. J Neurosci 29: 12815–12823.
47. El-Maarri O (2004) SIRPH analysis: SNuPE with IP-RP-HPLC for quantitative
measurements of DNA methylation at specific CpG sites. Methods Mol Biol 287:
195–205.
48. El-Maarri O, Herbiniaux U, Walter J, Oldenburg J (2002) A rapid, quantitative,
non-radioactive bisulfite-SNuPE- IP RP HPLC assay for methylation analysis at
specific CpG sites. Nucleic Acids Res 30: e25.
49. Tost J, Dunker J, Gut IG (2003) Analysis and quantification of multiple
methylation variable positions in CpG islands by Pyrosequencing. Biotechniques
35: 152–156.
50. Wilson VS, Bobseine K, Gray LE, Jr. (2004) Development and characterization
of a cell line that stably expresses an estrogen-responsive luciferase reporter for
the detection of estrogen receptor agonist and antagonists. Toxicol Sci 81:
69–77.
51. Wilson VS, Bobseine K, Lambright CR, Gray LE, Jr. (2002) A novel cell line,
MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive
reporter for the detection of hormone receptor agonists and antagonists. Toxicol
Sci 66: 69–81.
52. Swerdloff RS, Wang C (1998) Dihydrotestosterone: a rationale for its use as a
non-aromatizable androgen replacement therapeutic agent. Baillieres Clin
Endocrinol Metab 12: 501–506.
53. Zhao Z, Fan L, Frick KM (2010) Epigenetic alterations regulate estradiol-
induced enhancement of memory consolidation. Proc Natl Acad Sci U S A 107:
5605–5610.
Parameters Affecting LINE-1 Methylation
PLoS ONE | www.plosone.org 10 January 2011 | Volume 6 | Issue 1 | e16252